-
Ind-Swift Ltd Q3FY23 Results: Net Profit Rises 55% to Rs 86.74 Cr
Ind-Swift Ltd has reported a 55% increase in its net profit to Rs 86.74 crore for the third quarter of the financial year 2022-23 (Q3FY23), as compared to Rs 56.02 crore in the corresponding quarter of the previous fiscal.
-
Ind-Swift Ltd Partners with Pernod Ricard India to Distribute Select Portfolio of Whiskies
Ind-Swift Ltd has entered into a partnership with Pernod Ricard India to distribute a select portfolio of whiskies in India. Under the terms of the agreement, Ind-Swift will distribute Pernod Ricard India's Imperial Blue, Royal Stag, Blenders Pride, and 100 Pipers whiskies in select markets across India.
-
Ind-Swift Ltd Launches New Campaign for its Whisky Brand, 'Officer's Choice'
Ind-Swift Ltd has launched a new campaign for its whisky brand, 'Officer's Choice', featuring Bollywood actor Ajay Devgn. The campaign is aimed at highlighting the brand's strong association with the Indian armed forces and its commitment to providing quality products to consumers.
-
Ind-Swift Ltd. Q3FY23 Results: Net Profit Rises 13.5% YoY to Rs 123.15 Crore
Ind-Swift Ltd. has reported a 13.5% year-on-year (YoY) increase in its net profit to Rs 123.15 crore for the third quarter of the financial year 2023 (Q3FY23). The company's revenue from operations also grew by 11.7% YoY to Rs 930.94 crore during the quarter under review.
-
Ind-Swift Ltd. Partners with Jubilant Pharmova to Market and Distribute NCEs in India
Ind-Swift Ltd. has entered into a strategic partnership with Jubilant Pharmova Limited to market and distribute new chemical entities (NCEs) in India. Under the terms of the agreement, Ind-Swift will leverage its extensive distribution network to market and distribute Jubilant's NCEs in India.
-
Ind-Swift Ltd. Receives US FDA Approval for Abbreviated New Drug Application (ANDA) of Montelukast Sodium Tablets
Ind-Swift Ltd. has announced that it has received approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) of Montelukast Sodium Tablets, 10 mg. Montelukast Sodium Tablets are indicated for the treatment of asthma and seasonal allergic rhinitis.